These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19355912)

  • 1. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.
    Polyzos SA; Kountouras J; Zavos C
    Curr Mol Med; 2009 Apr; 9(3):299-314. PubMed ID: 19355912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis.
    Tilg H
    Curr Pharm Des; 2010 Jun; 16(17):1893-5. PubMed ID: 20370678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
    Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
    Schäffler A; Schölmerich J; Büchler C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adipocytokines and nonalcoholic steatohepatitis].
    Lăcătuşu C; Mihai B; Mihai C; Cijevschi-Prelipcean C; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):345-52. PubMed ID: 21495339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
    Orlik B; Handzlik G; Olszanecka-Glinianowicz M
    Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease.
    Tönjes A; Blüher M; Stumvoll M
    Curr Pharm Des; 2010 Jun; 16(17):1921-8. PubMed ID: 20370670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adipocitokines and nonalcoholic steatohepatitis].
    Lăcătuşu C; Mihai B; Cijevschi-Prelipcean C; Mihai C; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):882-9. PubMed ID: 20209757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytokines in non-alcoholic fatty liver disease.
    Tilg H
    Dig Dis; 2010; 28(1):179-85. PubMed ID: 20460908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
    Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
    World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].
    Chellali S; Boudiba A; Griene L; Koceir EA
    Ann Biol Clin (Paris); 2019 Jun; 77(3):261-271. PubMed ID: 30998190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines in nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1062-79. PubMed ID: 26725002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.
    Grønbaek H; Thomsen KL; Rungby J; Schmitz O; Vilstrup H
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):705-11. PubMed ID: 19072347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines and redox signaling: impact on fatty liver disease.
    Parola M; Marra F
    Antioxid Redox Signal; 2011 Jul; 15(2):461-83. PubMed ID: 21194387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mechanisms in the regulation of insulin resistance.
    Tilg H; Moschen AR
    Mol Med; 2008; 14(3-4):222-31. PubMed ID: 18235842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
    Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
    Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.